HARBOURVEST PARTNERS LLC - Q4 2021 holdings

$782 Million is the total value of HARBOURVEST PARTNERS LLC's 67 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 0.0% .

 Value Shares↓ Weighting
W  Wayfair, Inc.$201,772,000
-25.7%
1,062,1260.0%25.79%
+1.2%
SWI  Solarwinds Corp.$52,781,000
-15.2%
3,719,6000.0%6.75%
+15.4%
 N-Able, Inc.$41,288,000
-10.6%
3,719,6000.0%5.28%
+21.7%
 Omega Therapeutics, Inc.$29,991,000
-39.9%
2,647,0590.0%3.83%
-18.2%
 Outbrain Inc.$22,680,000
-5.4%
1,620,0000.0%2.90%
+28.7%
EVLO  Evelo Biosciences, Inc.$18,595,000
-13.8%
3,063,5050.0%2.38%
+17.3%
FTCH  Farfetch Ltd.ordinary shares cla$14,800,000
-10.8%
442,7160.0%1.89%
+21.4%
BHG  Bright Health Group, Inc.$14,509,000
-57.8%
4,217,7150.0%1.85%
-42.7%
RUBY  Rubius Therapeutics, Inc.$9,553,000
-45.9%
986,8780.0%1.22%
-26.3%
RLAY  Relay Therapeutics, Inc.$9,103,000
-2.6%
296,4020.0%1.16%
+32.6%
AXLA  Axcella Health, Inc.$5,869,000
-29.9%
2,807,9810.0%0.75%
-4.6%
KLDO  Kaleido BioSciences, Inc.$4,383,000
-56.2%
1,833,8320.0%0.56%
-40.5%
TWLO  Twilio, Inc.$3,837,000
-17.5%
14,5720.0%0.49%
+12.1%
NARI  Inari Medical$3,518,000
+12.5%
38,5400.0%0.45%
+53.1%
ZUO  Zuora, Inc.$3,062,000
+12.7%
163,8940.0%0.39%
+53.3%
IBRX  ImmunityBio, Inc.$2,041,000
-37.6%
335,7090.0%0.26%
-15.0%
SGTX  Sigilon Therapeutics, Inc.$2,044,000
-51.2%
740,7400.0%0.26%
-33.6%
ONTF  ON24, Inc.$1,895,000
-13.0%
109,2100.0%0.24%
+18.0%
YEXT  Yext, Inc.$1,142,000
-17.5%
115,1470.0%0.15%
+12.3%
ROOT  Root, Inc.$633,000
-41.2%
204,3140.0%0.08%
-19.8%
PACB  Pacific Biosciences of California, Inc.$480,000
-20.0%
23,4840.0%0.06%
+8.9%
DCT  Duck Creek Technologies, Inc.$437,000
-31.9%
14,5080.0%0.06%
-6.7%
MCRB  Seres Therapeutics, Inc.$411,000
+19.5%
49,3630.0%0.05%
+65.6%
CTMX  Cytomx Therapeutics, Inc.$343,000
-14.9%
79,1930.0%0.04%
+15.8%
RPTX  Repare Therapeutics, Inc.$259,000
-19.6%
12,2760.0%0.03%
+10.0%
ALGS  Aligos Therapeutics, Inc.$223,000
-23.4%
18,7830.0%0.03%
+7.4%
OYST  Oyster Point Pharma, Inc.$229,000
+53.7%
12,5600.0%0.03%
+107.1%
EPZM  Epizyme, Inc.$62,000
-50.8%
24,6860.0%0.01%
-33.3%
NXTC  NextCure, Inc.$60,000
-11.8%
10,0440.0%0.01%
+33.3%
YMTX  Yumanity$65,000
-71.4%
22,0300.0%0.01%
-61.9%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Wayfair, Inc.25Q3 202383.5%
Trevena, Inc.25Q4 20211.2%
Finjan Holdings, Inc.23Q2 202018.5%
Zuora, Inc.21Q3 20233.4%
Evelo Biosciences, Inc.20Q1 202326.3%
CytomX Therpeutics, Inc.19Q4 20212.3%
LendingClub Corp.18Q3 201911.9%
Rubius Therapeutics, Inc.18Q4 202221.4%
Solarwinds Corp.17Q4 202260.4%
Axcella Health, Inc.17Q2 20236.7%

View HARBOURVEST PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HARBOURVEST PARTNERS LLC Q4 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SolarWinds CorpFebruary 14, 20223,719,6002.3%
N-able, Inc.December 20, 20213,719,6002.1%
OncoMed Pharmaceuticals IncFebruary 14, 20191,901,1064.9%
Wayfair Inc.February 16, 20162,115,2964.6%
ENVIVIO INCFebruary 13, 20133,639,93913.5%
NETWORK ENGINES INCSold outFebruary 13, 201300.0%
VOCALTEC COMMUNICATIONS LTDAugust 06, 2010243,6892.1%
CERAGON NETWORKS LTDSold outJuly 26, 200700.0%
VISTAPRINT LTDSold outFebruary 14, 200700.0%
VOCALTEC COMMUNICATIONS LTDMay 26, 20061,218,44424.4%

View HARBOURVEST PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
40-APP2024-04-24
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR/A2022-05-26

View HARBOURVEST PARTNERS LLC's complete filings history.

Compare quarters

Export HARBOURVEST PARTNERS LLC's holdings